Ensayo clínico

Pharmacologic Augmentation of TMS for Depression With D-serine

NCT: NCT06876129 · RECRUITING

ID NCTNCT06876129

EstadoRECRUITING

Fecha de inicio2025-04-01

Finalización2027-04-01

SponsorMclean Hospital (OTHER)

First posted2025-03-14

Last updated2026-05-15

Resumen breve

The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce greater clinical outcomes than iTBS with placebo and 18-Hz with placebo.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.